These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1819740)
1. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF). Sagach VF; Dmitrieva AV; Braquet P Lipids; 1991 Dec; 26(12):1400-3. PubMed ID: 1819740 [TBL] [Abstract][Full Text] [Related]
2. [The role of the thrombocyte-activating factor in the development of circulatory disorders in the postischemic shock reaction]. Sagach VF; Dmitrieva AV Fiziol Zh (1978); 1990; 36(4):8-14. PubMed ID: 2172032 [TBL] [Abstract][Full Text] [Related]
3. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog. Filep JG; Braquet P; Mózes T Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856 [TBL] [Abstract][Full Text] [Related]
5. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. Filep J; Hermán F; Braquet P; Mózes T Biochem Biophys Res Commun; 1989 Jan; 158(2):353-9. PubMed ID: 2916986 [TBL] [Abstract][Full Text] [Related]
6. Evidence of a role for PAF-acether in the pathophysiology of the shock state. Sanchez Crespo M; Inarrea P; Nieto ML; Fernandez-Gallardo S Pharmacol Res Commun; 1986 Aug; 18 Suppl():181-96. PubMed ID: 3774844 [TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent effects of platelet-activating factor in the coronary circulation. Sagach VF; Zhukova AV; Braquet P J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S85-9. PubMed ID: 1282996 [TBL] [Abstract][Full Text] [Related]
8. [Cardio- and hemodynamics of dogs during the development of postischemic shock reaction]. Sagach VF; Dmitrieva AV Fiziol Zh (1978); 1989; 35(4):9-15. PubMed ID: 2792447 [TBL] [Abstract][Full Text] [Related]
9. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist. Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292 [TBL] [Abstract][Full Text] [Related]
10. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs. Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577 [TBL] [Abstract][Full Text] [Related]
11. Involvement of platelet activating factor in microcirculatory disturbances after global hepatic ischemia. Minor T; Isselhard W; Yamaguchi T J Surg Res; 1995 May; 58(5):536-40. PubMed ID: 7745967 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. Maruyama M; Farber NE; Vercellotti GM; Jacob HS; Gross GJ Am Heart J; 1990 Sep; 120(3):510-20. PubMed ID: 2389687 [TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor (PAF)-induced cardiopulmonary dysfunctions and their reversal with a PAF antagonist (BN 52021) in strain 13 guinea pigs. Qian C; Guo ZM; Peters CJ; Liu CT J Lipid Mediat; 1993 Jul; 7(3):223-37. PubMed ID: 8219003 [TBL] [Abstract][Full Text] [Related]
14. The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion. Wainwright CL; Parratt JR; Bigaud M Eur Heart J; 1989 Mar; 10(3):235-43. PubMed ID: 2468494 [TBL] [Abstract][Full Text] [Related]
15. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. Sirén AL; Feuerstein G Am J Physiol; 1989 Jul; 257(1 Pt 2):H25-32. PubMed ID: 2546449 [TBL] [Abstract][Full Text] [Related]
16. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock. De Kimpe SJ; Thiemermann C; Vane JR Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795 [TBL] [Abstract][Full Text] [Related]
17. Effects of platelet activating factor (PAF) and its receptor antagonist BN 52021 on isolated perfused guinea-pig heart. Viossat I; Chapelat M; Chabrier PE; Braquet P Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):189-94. PubMed ID: 2622972 [TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats. López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516 [TBL] [Abstract][Full Text] [Related]
19. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart. Hu W; Kinnaird AA; Man RY Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]